{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:11:29Z","timestamp":1777590689705,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,28]],"date-time":"2017-04-28T00:00:00Z","timestamp":1493337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.vaccine.2017.04.075","type":"journal-article","created":{"date-parts":[[2017,5,4]],"date-time":"2017-05-04T18:00:19Z","timestamp":1493920819000},"page":"3209-3214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Needle adapters for intradermal administration of fractional dose of inactivated poliovirus vaccine: Evaluation of immunogenicity and programmatic feasibility in Pakistan"],"prefix":"10.1016","volume":"35","author":[{"given":"Ali Faisal","family":"Saleem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ondrej","family":"Mach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad T.","family":"Yousafzai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asia","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William C.","family":"Weldon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Steven","family":"Oberste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland W.","family":"Sutter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita K.M.","family":"Zaidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.04.075_b0005","unstructured":"Cases of wild poliovirus by country and year. Available at: http:\/\/www.polioeradication.org\/Dataandmonitoring\/Poliothisweek\/Wildpolioviruslist.aspx [accessed 12\/20\/2016]."},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.04.075_b0010","doi-asserted-by":"crossref","first-page":"S434","DOI":"10.1093\/infdis\/jiu222","article-title":"The new polio eradication end game: rationale and supporting evidence","volume":"210","author":"Sutter","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.04.075_b0015","first-page":"222","article-title":"Apparent global interruption of wild poliovirus type 2 transmission","volume":"50","author":"Centers for Disease C, Prevention","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2017.04.075_b0020","unstructured":"GPEI. Global switch in oral polio vaccines. Available at: http:\/\/maps.who.int\/OPV_switch\/ [accessed 07\/06\/2016]."},{"key":"10.1016\/j.vaccine.2017.04.075_b0025","unstructured":"WHO. Outbreak response: a package of guidelines and materials. Available at: http:\/\/www.polioeradication.org\/Resourcelibrary\/Resourcesforpolioeradicators\/Technicalguidelines.aspx."},{"key":"10.1016\/j.vaccine.2017.04.075_b0030","unstructured":"SAGE. SAGE discussion and statement in relation with the IPV supply situation. Available at: http:\/\/www.who.int\/immunization\/sage\/meetings\/2016\/april\/SAGE_statement_IPV_situation.pdf [accessed 23\/06\/2016]."},{"key":"10.1016\/j.vaccine.2017.04.075_b0035","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.1016\/j.vaccine.2015.06.071","article-title":"Needle-free jet injector intradermal delivery of fractional dose inactivated poliovirus vaccine: association between injection quality and immunogenicity","volume":"33","author":"Resik","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.075_b0040","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1056\/NEJMoa0909383","article-title":"Fractional doses of inactivated poliovirus vaccine in Oman","volume":"362","author":"Mohammed","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.04.075_b0045","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0264-410X(97)00293-4","article-title":"Immune response of infants to fractional doses of intradermally administered inactivated poliovirus vaccine","volume":"16","author":"Nirmal","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.075_b0050","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.vaccine.2014.11.025","article-title":"Immune responses after fractional doses of inactivated poliovirus vaccine using newly developed intradermal jet injectors: a randomized controlled trial in Cuba","volume":"33","author":"Resik","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.075_b0055","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S1473-3099(11)70190-6","article-title":"Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6\u20139 months in Moradabad, India: a community-based, randomised controlled trial","volume":"12","author":"Estivariz","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2017.04.075_b0060","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1016\/j.vaccine.2013.05.104","article-title":"Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults","volume":"31","author":"Soonawala","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.075_b0065","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.vaccine.2011.11.018","article-title":"Intradermal fractional dose inactivated polio vaccine: a review of the literature","volume":"30","author":"Nelson","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.075_b0070","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1086\/651611","article-title":"Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in Cuba","volume":"201","author":"Resik","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.04.075_b0075","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJMoa1202541","article-title":"Priming after a fractional dose of inactivated poliovirus vaccine","volume":"368","author":"Resik","year":"2013","journal-title":"N Engl J Med"},{"issue":"March","key":"10.1016\/j.vaccine.2017.04.075_b0080","first-page":"145","article-title":"Polio vaccines: WHO position paper","volume":"91","year":"2016","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2017.04.075_b0085","first-page":"237","article-title":"Combined use of inactivated and oral poliovirus vaccines in refugee camps and surrounding communities \u2013 Kenya, December 2013","volume":"63","author":"Sheikh","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2017.04.075_b0090","unstructured":"WestPharma. Introducing the west intradermal adapter. Available at: http:\/\/www.westpharma.com\/en\/events\/Pages\/7832-RN-ID-Adapter.aspx [accessed 08\/06\/2016]."},{"key":"10.1016\/j.vaccine.2017.04.075_b0095","unstructured":"Syringe S. Star ID: intradermal delivery made easy. Available at: http:\/\/www.starsyringe.com\/product-starid.htm."},{"key":"10.1016\/j.vaccine.2017.04.075_b0100","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1749-6632.1995.tb44462.x","article-title":"Defining surrogate serologic tests with respect to predicting protective vaccine efficacy: poliovirus vaccination","volume":"754","author":"Sutter","year":"1995","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.vaccine.2017.04.075_b0105","unstructured":"WHO Expanded Programme on Immunization. World Health Organization. Division of communicable diseases. Manual for the virological investigation of poliomyelitis. Geneva: World Health Organization; 1990."},{"key":"10.1016\/j.vaccine.2017.04.075_b0110","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.clim.2003.11.011","article-title":"Search for poliovirus long-term excretors among patients affected by agammaglobulinemia","volume":"111","author":"Fiore","year":"2004","journal-title":"Clin Immunol"},{"key":"10.1016\/j.vaccine.2017.04.075_b0115","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-4939-3292-4_8","article-title":"Standardized methods for detection of poliovirus antibodies","volume":"1387","author":"Weldon","year":"2016","journal-title":"Methods Mol Biol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17305765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17305765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T00:23:08Z","timestamp":1535847788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17305765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":23,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0264410X17305765"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.04.075","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Needle adapters for intradermal administration of fractional dose of inactivated poliovirus vaccine: Evaluation of immunogenicity and programmatic feasibility in Pakistan","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.04.075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}